FILARIASIS-RELATED ACUTE ADENOLYMPHANGITIS: EXPLORING FACTORS AND TREATMENT OPTIONS

Abstract

Aim: This study aims to evaluate the precipitating factors of acute adenolymphangitis (ADL) in patients with lymphatic filariasis and compare the efficacy of various treatment modalities.

Material and Methods: A total of 50 patients were enrolled and randomly assigned to three treatment groups: symptomatic treatment, symptomatic treatment with antibiotics, and symptomatic treatment with diethylcarbamazine (DEC). Data was collected on the number of ADL attacks, presence of infection, and ASO titer levels.

Results: Antibiotics and DEC provided better outcomes, with lower recurrence rates and faster resolution of symptoms.

Conclusion: This study highlights the importance of comprehensive management strategies in preventing recurrent ADL episodes and improving patient outcomes.